{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:54:14Z","timestamp":1780422854023,"version":"3.54.1"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Pharmacovigilance reports have suggested that certain commonly used medications may trigger autoimmune diseases (ADs) and immune-mediated inflammatory diseases (IMIDs). We systematically reviewed the literature to evaluate whether psychiatric medication use is associated with ADs and IMIDs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The protocol was registered in PROSPERO (CRD42022296524) before the start of the study. We searched Medline Ovid and Scopus up to November 28<jats:sup>th<\/jats:sup>, 2021, for comparative studies, with any psychiatric medication as exposure and ADs and IMIDs as outcomes. Meta-analysis was performed using DerSimonian-Laird random-effects modeling. The PRISMA 2020 guidelines were followed in reporting. Study-level risk of bias was assessed using the Newcastle-Ottawa Scale, and the overall certainty of evidence using GRADE.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>There were 7,265 citations from which 31 studies were eligible, all from high-income countries, covering 15 distinct immune diseases. The evidence for the association between selective serotonin reuptake inhibitor (SSRI) use and higher risk of microscopic colitis (meta-OR 2.60, 95% CI 1.05\u20136.39, I<jats:sup>2<\/jats:sup> 97.5%, 6 studies) was of low certainty. A subgroup analysis by the histological type of microscopic colitis showed a statistically significant association only with lymphocytic colitis (meta-OR 2.88, 95% CI 2.60\u20133.18, I<jats:sup>2<\/jats:sup> 00.00%, three studies). In two case-control studies, SSRI use had no significant association with psoriasis (meta-OR 0.80, 95% CI 0.58\u20131.10, I<jats:sup>2<\/jats:sup> 82.4%). The risk of acute pancreatitis was slightly increased with exposure to SSRIs (meta-OR 1.13, 95% CI 1.01\u20131.26, I<jats:sup>2<\/jats:sup> 00.0%), as was the risk of bullous pemphigoid after exposure to antipsychotics (meta-OR 1.79, 95% CI 1.17\u20132.73, I<jats:sup>2<\/jats:sup> 0%).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We reviewed the literature on whether psychiatric medications associate with the risk of ADs and IMIDs and concluded that, despite several signals, the credibility of evidence remains low at best. Prospective cohort studies would be needed as the next step to confirm the suggestions of increased risk.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0281979","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T19:49:13Z","timestamp":1677613753000},"page":"e0281979","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8978-7502","authenticated-orcid":true,"given":"Ilmari","family":"Larivuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Laukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nevalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otso","family":"Arponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli P. O.","family":"Nevalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"issue":"6","key":"pone.0281979.ref001","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"MD Rosenblum","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"pone.0281979.ref002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","article-title":"The World Incidence and Prevalence of Autoimmune Diseases is Increasing","volume":"3","author":"A Lerner","year":"2015","journal-title":"Int J Celiac Dis"},{"issue":"1","key":"pone.0281979.ref003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2050640620951905","article-title":"European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations","volume":"9","author":"S Miehlke","year":"2021","journal-title":"UEG Journal"},{"issue":"4","key":"pone.0281979.ref004","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MIB.0000000000001059","article-title":"Antidepressants in Inflammatory Bowel Disease: A Systematic Review","volume":"23","author":"BJ Macer","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0281979.ref005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1422.019","article-title":"Drug-induced lupus","volume":"1108","author":"AT Borchers","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"pone.0281979.ref006","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/jcm9072212","article-title":"Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia","volume":"9","author":"C Vayne","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"pone.0281979.ref007","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Y Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"pone.0281979.ref008","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.jadr.2021.100177","article-title":"A chicken and egg scenario in psychoneuroimmunology: Bidirectional mechanisms linking cytokines and depression","volume":"6","author":"M Rengasamy","year":"2021","journal-title":"J Affect Disord Rep"},{"issue":"3","key":"pone.0281979.ref009","doi-asserted-by":"crossref","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"MJ Page","year":"2021","journal-title":"PLoS Med"},{"key":"pone.0281979.ref010","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses","author":"G SB Wells","year":"2000","journal-title":"3rd Symposium on Systematic Reviews: Beyond the Basics"},{"key":"pone.0281979.ref011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence.","volume":"64","author":"H Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"pone.0281979.ref012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"key":"pone.0281979.ref013","author":"JPT Higgins"},{"key":"pone.0281979.ref014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2288-8-8","article-title":"The harvest plot: a method for synthesising evidence about the differential effects of interventions","volume":"8","author":"D Ogilvie","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"pone.0281979.ref015","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/MIB.0000000000000143","article-title":"Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases","volume":"20","author":"OK Bonderup","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"pone.0281979.ref016","first-page":"411","article-title":"Epidemiological risk factors in microscopic colitis: a prospective case-control study","volume":"19","author":"F Fern\u00e1ndez-Ba\u00f1ares","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"pone.0281979.ref017","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1572-0241.2006.00902.x","article-title":"Drug consumption and the risk of microscopic colitis","volume":"102","author":"F Fern\u00e1ndez-Ba\u00f1ares","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"pone.0281979.ref018","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ajg.2015.119","article-title":"Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs","volume":"110","author":"GM Masclee","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"pone.0281979.ref019","first-page":"11","article-title":"Microscopic colitis and Medication Use","volume":"2010","author":"MF Pascua","year":"2010","journal-title":"Clin Med Insights Gastroenterol"},{"issue":"9","key":"pone.0281979.ref020","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/apt.13583","article-title":"High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors","volume":"43","author":"BP Verhaegh","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"pone.0281979.ref021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ecco-jcc\/jjab119","article-title":"Microscopic Colitis in Denmark: Regional Variations in Risk Factors and Frequency of Endoscopic Procedures","volume":"16","author":"P Weimers","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"3","key":"pone.0281979.ref022","doi-asserted-by":"crossref","first-page":"e000914","DOI":"10.1136\/bmjopen-2012-000914","article-title":"Antidopaminergic drugs and acute pancreatitis: a population-based study","volume":"2","author":"R Bod\u00e9n","year":"2012","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0281979.ref023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1592\/phco.28.1.27","article-title":"Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study","volume":"28","author":"C Gasse","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"12","key":"pone.0281979.ref024","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00228-017-2328-x","article-title":"Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan","volume":"73","author":"HF Lin","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"pone.0281979.ref025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/JCP.0b013e318253d71a","article-title":"Selective serotonin reuptake inhibitors and the risk of acute pancreatitis: a Swedish population-based case-control study","volume":"32","author":"R Ljung","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"pone.0281979.ref026","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00045391-200603000-00005","article-title":"Valproic acid and risk of acute pancreatitis: a population-based case-control study","volume":"13","author":"M N\u00f8rgaard","year":"2006","journal-title":"Am J Ther"},{"issue":"3","key":"pone.0281979.ref027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/JCP.0b013e318058a9c3","article-title":"Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study","volume":"27","author":"M N\u00f8rgaard","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"pone.0281979.ref028","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"S Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol"},{"issue":"3","key":"pone.0281979.ref029","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"S Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"1","key":"pone.0281979.ref030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a UK case-control study","volume":"149","author":"A Lloyd-Lavery","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"pone.0281979.ref031","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaad.2019.02.017","article-title":"Drugs used for neurologic and psychiatric conditions increase the risk for bullous pemphigoid: A case-control study","volume":"81","author":"O Varpuluoma","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"pone.0281979.ref032","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"CM Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"issue":"12","key":"pone.0281979.ref033","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamapsychiatry.2018.2462","article-title":"Association of Depression With Risk of Incident Systemic Lupus Erythematosus in Women Assessed Across 2 Decades","volume":"75","author":"AL Roberts","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"pone.0281979.ref034","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2125.2010.03733.x","article-title":"Do selected drugs increase the risk of lupus? A matched case-control study","volume":"70","author":"WM Schoonen","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"pone.0281979.ref035","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/1346-8138.15931","article-title":"Association of depression and alopecia areata in women: A prospective study","volume":"48","author":"MA Mirza","year":"2021","journal-title":"J Dermatol"},{"issue":"4","key":"pone.0281979.ref036","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jamadermatol.2018.4398","article-title":"Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata","volume":"155","author":"IA Vallerand","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"pone.0281979.ref037","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/JCP.0b013e31819a4b7c","article-title":"Lithium, antipsychotics, and risk of psoriasis","volume":"29","author":"YB Brauchli","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"pone.0281979.ref038","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jad.2020.11.110","article-title":"Protective Effects of Anti-depressants against the Subsequent Development of Psoriasis in Patients with Major Depressive Disorder: a Cohort Study","volume":"281","author":"YM Tzeng","year":"2021","journal-title":"J Affect Disord"},{"issue":"1","key":"pone.0281979.ref039","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.24441","article-title":"Depression and Subsequent Risk for Incident Rheumatoid Arthritis Among Women","volume":"73","author":"JA Sparks","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"pone.0281979.ref040","doi-asserted-by":"crossref","first-page":"e000670","DOI":"10.1136\/rmdopen-2018-000670","article-title":"Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study","volume":"4","author":"IA Vallerand","year":"2018","journal-title":"RMD Open"},{"issue":"5","key":"pone.0281979.ref041","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-011-1184-3","article-title":"Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study","volume":"68","author":"E Garbe","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0281979.ref042","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2147\/CIA.S144263","article-title":"The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case-control study","volume":"12","author":"T Rosenberg","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"3","key":"pone.0281979.ref043","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pds.3692","article-title":"The use of valproic acid and multiple sclerosis","volume":"24","author":"NM Nielsen","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"pone.0281979.ref044","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2001.01381.x","article-title":"Association between lithium use and thyrotoxicosis caused by silent thyroiditis","volume":"55","author":"KK Miller","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"pone.0281979.ref045","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaad.2018.11.047","article-title":"Vitiligo and major depressive disorder: A bidirectional population-based cohort study","volume":"80","author":"IA Vallerand","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"7109","key":"pone.0281979.ref046","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"pone.0281979.ref047","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200022010-00005","article-title":"Drug-induced diarrhoea","volume":"22","author":"O Chassany","year":"2000","journal-title":"Drug Saf"},{"key":"pone.0281979.ref048","article-title":"Autoimmune and immune-mediated inflammatory diseases after exposure to acid-suppressive medication: a systematic review and meta-analysis","volume":"10","author":"A Nevalainen","year":"2022","journal-title":"Int J Risk Saf Med"},{"issue":"3","key":"pone.0281979.ref049","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/joim.12093","article-title":"Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: a population-based cohort study","volume":"274","author":"K Thorslund","year":"2013","journal-title":"J Intern Med"},{"issue":"9468","key":"pone.0281979.ref050","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(05)66379-9","article-title":"Compared to what? Finding controls for case-control studies","volume":"365","author":"DA Grimes","year":"2005","journal-title":"Lancet"},{"key":"pone.0281979.ref051","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2017.07.015","article-title":"Increased incidence of psychiatric disorders in immune-mediated inflammatory disease","volume":"101","author":"RA Marrie","year":"2017","journal-title":"J Psychosom Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T19:49:43Z","timestamp":1677613783000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281979"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0281979","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}